

![]() |
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II study |
|
Authors | ||
Published in | Annals of Oncology. 2003, vol. 14, no. 1, p. 110-5 | |
Abstract | To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. | |
Keywords | Adenocarcinoma/drug therapy/radiotherapy — Aged — Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use — Cisplatin/administration & dosage — Combined Modality Therapy — Humans — Leucovorin/administration & dosage — Maximum Tolerated Dose — Neoadjuvant Therapy — Neoplasm Staging — Stomach Neoplasms/drug therapy/radiotherapy — Survival Rate | |
Identifiers | PMID: 12488302 | |
Full text | ||
Structures | ||
Research groups | Groupe Roth Arnaud (oncologie) (285) Chirurgie viscérale (104) | |
Citation (ISO format) | ROTH, Arnaud et al. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II study. In: Annals of Oncology, 2003, vol. 14, n° 1, p. 110-5. doi: 10.1093/annonc/mdg023 https://archive-ouverte.unige.ch/unige:45323 |